Magazine
Sign up for your free subscription and keep up-to-date.
Upcoming Events
Newsletters
Stay updated on the latest news and technologies with Bioscienceworld's newsletters.
Five to choose from.
Quote of the week
“Good research and development isn't enough to ensure a successful venture into biotech; neither is solely relying on a strong business background.”
- As quoted in the July issue of Biotechnology Focus.
Top Stories
|
Canada Foundation for Innovation invests $26 million to attract and retain best and brightest minds
The Canada Foundation for Innovation (CFI) announces a $26-million investment to help universities across the country attract and retain the best and brightest minds from Canada and around the world. The funds will provide infrastructure support for 136 projects at 40 universities, enabling 192 high-calibre investigators to conduct their research in world-class facilities.
|
|
Top nanotechnology researcher returns home
The University of New Brunswick has appointed Dr. Felipe Chibante as the Richard J. Currie Chair in Nanotechnology in the Faculty of Engineering.
|
|
BIOTECanada announces new appointments to board of directors for 2007-2008
BIOTECanada, announces the 2007-2008 board of directors during the Annual General Meeting last month in Montreal, QC.
|
|
Neuromed appoints Dr. William L. Hunter as chairman of board of directors
Neuromed Pharmaceuticals announces that Dr. William L. Hunter has been appointed chairman of Neuromed's Board of Directors. Dr. Hunter is co-founder and president and CEO of Angiotech Pharmaceuticals, Inc. and has served as a director on Neuromeds board since 2004.
|
|
Structural Genomics Consortium initiates new phase to solve protein structures
The Structural Genomics Consortium (SGC) gains new funding of more than $105 million to support a second, four-year phase beginning July 2007.
|
Spotlight
|
Protein overexpression in Escherichia coli: Engineering bugs to make them more productive in protein synthesis and more robust when being cultured
Proteins are useful bioproducts which frequently need to be produced in large amounts for scientific characterization or practical (such as industrial or medical) applications. Even with the development of the cell-free system, most campaigns in protein production will require a specific type of biological cell as the host.
|